The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative.

Current Osteoporosis Reports
Rebecca D Jackson, Shubhangi Shidham

Abstract

Osteoporosis, a major public health problem, is characterized by increased risk for fracture. To reduce the morbidity and excess loss of life associated with this common disease, we need to understand the efficacy of treatment strategies for fracture reduction. The Women's Health Initiative Clinical Trials have extended our understanding of the effect of hormone therapy and calcium plus vitamin D supplements on risk for hip and total fractures. Although estrogen, with or without progestin, significantly decreases fracture risk at all skeletal sites-almost irrespective of underlying risk for osteoporosis-its risks outweigh its benefits, negating its general use for fracture reduction. For calcium-replete women, calcium plus vitamin D supplementation has a non-significant effect, hence the case for universal supplementation loses merit. But, that argument gains credibility for women over age 60-as a 21% reduction in hip fractures attests-showing that calcium plus vitamin D has a positive effect on bone health in older postmenopausal women.

References

Dec 3, 1992·The New England Journal of Medicine·M C ChapuyP J Meunier
Oct 1, 1990·Calcified Tissue International·R G Cumming
Nov 20, 1980·The New England Journal of Medicine·N S WeissJ R Daling
Jan 14, 2000·The Journal of Clinical Endocrinology and Metabolism·E Barrett-ConnorD J Sartoris
May 5, 2000·The Cochrane Database of Systematic Reviews·W J GillespieJ Robertson
May 2, 2001·The Cochrane Database of Systematic Reviews·W J GillespieJ Robertson
Jun 13, 2001·JAMA : the Journal of the American Medical Association·D J Torgerson, S E Bell-Syer
Nov 22, 2001·BMC Musculoskeletal Disorders·D J Torgerson, S E Bell-Syer
May 22, 2002·JAMA : the Journal of the American Medical Association·Robert LindsayJames H Pickar
Jun 7, 2002·Lancet·Steven R Cummings, L Joseph Melton
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Heidi D NelsonJanet D Allan
Aug 31, 2002·Endocrine Reviews·George WellsUNKNOWN Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
Aug 31, 2002·Endocrine Reviews·Beverley SheaUNKNOWN Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
May 29, 2003·JAMA : the Journal of the American Medical Association·Stephen R RappUNKNOWN WHIMS Investigators
May 29, 2003·JAMA : the Journal of the American Medical Association·Sylvia Wassertheil-SmollerUNKNOWN WHI Investigators
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators
Aug 9, 2003·The New England Journal of Medicine·JoAnn E MansonUNKNOWN Women's Health Initiative Investigators
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Jane A CauleyUNKNOWN Women's Health Initiative Investigators
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
Apr 29, 2004·JAMA : the Journal of the American Medical Association·Heike A Bischoff-FerrariJohn B Wong
May 13, 2004·JAMA : the Journal of the American Medical Association·Emily BanksUNKNOWN Million Women Study Collaborators
Jun 19, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Julie A PascoGeoffrey C Nicholson
Jun 24, 2004·JAMA : the Journal of the American Medical Association·Sally A ShumakerUNKNOWN Women's Health Initiative Memory Study
Oct 7, 2004·JAMA : the Journal of the American Medical Association·Mary CushmanUNKNOWN Women's Health Initiative Investigators
May 12, 2005·Lancet·Philip Sambrook
May 12, 2005·JAMA : the Journal of the American Medical Association·Heike A Bischoff-FerrariBess Dawson-Hughes
Feb 16, 2006·Archives of Internal Medicine·Judith HsiaUNKNOWN Women's Health Initiative Investigators
Feb 17, 2006·The New England Journal of Medicine·Rebecca D JacksonUNKNOWN Women's Health Initiative Investigators
Apr 12, 2006·Archives of Internal Medicine·J David CurbFrits R Rosendaal
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Marcia L StefanickUNKNOWN WHI Investigators
May 17, 2006·Circulation·Susan L HendrixUNKNOWN WHI Investigators
Jun 7, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Rebecca D JacksonUNKNOWN Women's Health Initiative Investigators
Apr 5, 2007·JAMA : the Journal of the American Medical Association·Jacques E RossouwMarcia L Stefanick
Jun 22, 2007·The New England Journal of Medicine·Joann E MansonUNKNOWN WHI and WHI-CACS Investigators

❮ Previous
Next ❯

Citations

Nov 13, 2009·The American Journal of Clinical Nutrition·D Lee AlekelC Theodore Peterson
Aug 22, 2015·Expert Opinion on Drug Discovery·Luigi GennariDaniela Merlotti
Feb 1, 2011·Expert Opinion on Drug Discovery·Luigi GennariRanuccio Nuti
Nov 26, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Paul D Miller
Apr 8, 2016·Expert Opinion on Pharmacotherapy·Luigi GennariDaniela Merlotti
Jan 15, 2014·The Cochrane Database of Systematic Reviews·Goran BjelakovicChristian Gluud
Jan 14, 2010·Clinical Pharmacokinetics·Teun M PostMeindert Danhof
Jun 24, 2014·The Cochrane Database of Systematic Reviews·Goran BjelakovicChristian Gluud
Nov 1, 2010·Personalized Medicine·Wen-Feng LiJian-Min Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Obstetrics and Gynecology
R J Worley
Endocrinology and Metabolism Clinics of North America
Faryal S Mirza, Karen M Prestwood
Journal of the American Pharmaceutical Association : APhA
D S Carson
© 2022 Meta ULC. All rights reserved